Kinnate Biopharma Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Kinnate Biopharma Inc. has filed 250 SEC EDGAR filings since 23 Dec 2019

SEC filing history

Showing 1-25 of 250 matching filings.

Per page
25
Current page
1
SC 13G/A File 005-91893

SC 13G/A

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-39743

15-12G

Filing date
17 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91893

AMENDMENT NO. 6

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-270655

S-8 POS

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-263913

S-8 POS

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-251105

S-8 POS

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-261970

POSASR

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-91893

SC 14D9/A

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-39743

25-NSE filing

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-91893

SC TO-T/A

Filing date
03 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .